Tirzepatide reduces breast tumor growth in obese mice while improving metabolic health, offering hope as a dual-action cancer ...

Danish drugmaker Novo Nordisk is betting on its insulin leadership in India to dominate the country's $25-billion anti-obesity drug market with the imminent launch of its weight-loss therapy, a ...

Novo Nordisk is banking on its pen-filled device and insulin leadership in India to gain a strong market share despite ...

Generic drugmaker Viatris has become the first company to secure FDA approval for a biosimilar product that is considered completely interchangeable with the reference product – namely Sanofi's ...

The treatment has been around for over a century but insulin has still become the centre of the ongoing discussion over pricing of pharmaceutical products. Ben Hargreaves looks at why insulin’s ...

Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building an ...

In this 2025 public health alignment update, GlucoTru Pro emphasizes the growing consumer awareness of natural metabolic ...

Strength training for women evolves in 2025 as CrazyBulk supplements offer legal, female-friendly alternatives to anabolic ...

GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan Skrmetti.

The participants in the trial – similar to two-thirds of breast cancer patients overall - had tumors that use the hormones ...

Ozempic has gained a lot of popularity with many referring to it as the miracle weight loss drug However how much do you ...

Airlines have regulations for passengers who are travelling with their meds and each carrier is slightly different.